| 000 | 01264 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250513032529.0 | ||
| 264 | 0 | _c19951103 | |
| 008 | 199511s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(95)91552-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChin, D P | |
| 245 | 0 | 0 |
_aHow to treat bacteraemic Mycobacterium avium complex disease. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cOct 1995 |
||
| 300 |
_a920-1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xdrug therapy |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 |
_aBacteremia _xdrug therapy |
| 650 | 0 | 4 |
_aClarithromycin _xadverse effects |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMycobacterium avium-intracellulare Infection _xdrug therapy |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 |
_aRifabutin _xadverse effects |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHopewell, P C | |
| 773 | 0 |
_tLancet (London, England) _gvol. 346 _gno. 8980 _gp. 920-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(95)91552-4 _zAvailable from publisher's website |
| 999 |
_c7564179 _d7564179 |
||